Kim Trautman is a former US Food and Drug Administration official who’s currently managing director and VP of consulting firm MEDIcept Inc.
QMSR Quick Take: QSR Author Kim Trautman
Former US FDA official and longtime industry expert Kim Trautman gives a quick take on the agency’s proposed Quality Management System Regulation. The QMSR would replace the FDA’s current Quality System Regulation, which Trautman lead authored in the 1990s.

More from Regulation
Its move comes as the Swiss recognize the need to ensure adequate supplies on medical devices in its country.
As the EU Life Sciences Strategy aims to drive innovation, the medtech sector is pushing for a pivotal role in a mission intended to embrace green and digital transitions, address regulatory obstacles and reduce dependency on external sources.
The FDA's final LDT ruling was struck down in federal court last month. For now, diagnostic companies can commercialize under CLIA regulations or apply for FDA approval. McDermott and Tribun Health have shared insights on the risks, pros and cons of both regulatory routes.
Ireland’s NSAI reinstated under IVD Regulation designation list